Inventor profile of:

Michael Goldstein

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

23

Last publication date:

2025-10-30

Top Assignees for applications by Michael Goldstein

The entities that hold a legal rights for patent applications filed by inventor Goldstein Michael:

Recent patent applications by Goldstein Michael

Michael Goldstein from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-30
US20250332094A1
Human necessities

OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

#2 | 2025-08-28
US20250268818A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

#3 | 2025-04-03
US20250108003A1
Human necessities

METHODS OF TREATING ALLERGIC CONJUNCTIVITIS

#4 | 2025-02-20
US20250057759A1
Human necessities

SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE

#5 | 2024-05-23
US20240165018A1
Human necessities

HYDROGEL IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE

#6 | 2024-02-08
US20240041758A1
Human necessities

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

#7 | 2023-12-07
US20230390189A1
Human necessities

OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT

#8 | 2023-10-26
US20230338281A1
Human necessities

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent

#9 | 2023-09-14
US20230285282A1
Human necessities

OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT

#10 | 2023-09-14
US20230285281A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

#11 | 2023-04-20
US20230118774A1
Human necessities

OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

#12 | 2022-11-03
US20220347094A1
Human necessities

Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor

#13 | 2022-07-14
US20220218643A1
Human necessities

Methods of treating ocular diseases using polyalkylene glycol intracameral implants with polyactide travoprost particles

#14 | 2022-07-14
US20220218601A1
Human necessities

Methods of treating allergic conjunctivitis

#15 | 2022-06-30
US20220202706A1
Human necessities

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

#16 | 2022-06-16
US20220183969A1
Human necessities

OCULAR INSERT CONTAINING A GLUCOCORTICOID

#17 | 2022-03-24
US20220087932A1
Human necessities

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

#18 | 2022-03-24
US20220087931A1
Human necessities

Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

#19 | 2022-03-17
US20220079876A1
Human necessities

OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

#20 | 2021-10-07
US20210308043A1
Human necessities

Ocular implant containing a tyrosine kinase inhibitor

#21 | 2021-08-19
US20210251893A1
Human necessities

Compositions and Methods for Treating Ocular Diseases

#22 | 2020-10-29
US20200337993A1
Human necessities

INTRACANALICULAR HYDROGEL INSERTS FOR THE DELIVERY OF ANESTHETICS

#23 | 2020-10-29
US20200337990A1
Human necessities

HYDROGEL IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE

InventorID:

2889044 ⎘